EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, characterization, invitro anticancer evaluation, computational studies, and in silico ADME assessment of New N-(5-o-tolyl-1,3,4-oxadiazol-2-yl) alkanamides

Kadeer Md, Ravi Kumar Parangi, Ramesh Domala

Chemical Data Collections · 2024-12 · 54 · 101167

DOI: 10.1016/j.cdc.2024.101167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Data Collections, 2024-12. Verfasst von Kadeer Md und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Mahatma Gandhi University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Mahatma Gandhi University

Zitieren

APA

Md, K., Parangi, R. K., & Domala, R. (2024). Design, synthesis, characterization, invitro anticancer evaluation, computational studies, and in silico ADME assessment of New N-(5-o-tolyl-1,3,4-oxadiazol-2-yl) alkanamides. Chemical Data Collections, 54, 101167. https://doi.org/10.1016/j.cdc.2024.101167

Vancouver

Md K, Parangi RK, Domala R. Design, synthesis, characterization, invitro anticancer evaluation, computational studies, and in silico ADME assessment of New N-(5-o-tolyl-1,3,4-oxadiazol-2-yl) alkanamides. Chemical Data Collections. 2024;54:101167. doi:10.1016/j.cdc.2024.101167

BibTeX
@article{Md2024,
  author = {Md, Kadeer and Parangi, Ravi Kumar and Domala, Ramesh},
  title = {Design, synthesis, characterization, invitro anticancer evaluation, computational studies, and in silico ADME assessment of New N-(5-o-tolyl-1,3,4-oxadiazol-2-yl) alkanamides},
  journal = {Chemical Data Collections},
  year = {2024},
  volume = {54},
  pages = {101167},
  doi = {10.1016/j.cdc.2024.101167}
}
Kostenlos starten →